ApiFix received Therapeutic Goods Administration certification through its distributor, Orthotech, to market the ApiFix system in Australia to treat Adolescent Idiopathic Scoliosis.
The minimally invasive ApiFix system represents a non-fusion scoliosis treatment that is designed to maintain spinal flexibility and reduce hospitalization and OR time. The company also has CE Mark approval and markets the product in Germany, Greece, Israel, Italy, the Netherlands and most recently, Spain.
Sources: ApiFix; ORTHOWORLD Inc.
ApiFix received Therapeutic Goods Administration certification through its distributor, Orthotech, to market the ApiFix system in Australia to treat Adolescent Idiopathic Scoliosis.
The minimally invasive ApiFix system represents a non-fusion scoliosis treatment that is designed to maintain spinal flexibility and reduce hospitalization and OR...
ApiFix received Therapeutic Goods Administration certification through its distributor, Orthotech, to market the ApiFix system in Australia to treat Adolescent Idiopathic Scoliosis.
The minimally invasive ApiFix system represents a non-fusion scoliosis treatment that is designed to maintain spinal flexibility and reduce hospitalization and OR time. The company also has CE Mark approval and markets the product in Germany, Greece, Israel, Italy, the Netherlands and most recently, Spain.
Sources: ApiFix; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.